Abstract
The low solubility of active pharmaceutical ingredients (APIs) is a problem in pharmaceutical development. Several methodologies can be used to improve API solubility, including the use of eutectic systems in which one of the constituents is the API. This class of compounds is commonly called Therapeutic Deep Eutectic Systems (THEDES). THEDES has been gaining attention due to their properties such as non-toxicity, biodegradability, and being non-expensive and easy to prepare. Since the knowledge of the solid liquid diagram of the mixture and the ideal eutectic point is necessary to ascertain if a mixture is a deep eutectic or just a eutectic mixture that is liquid at ambient temperature, the systems studied in this work are called Therapeutic Liquid Eutectic Systems (THELES). Therefore, the strategy proposed in this work is to improve the solubility of chlorpropamide and tolbutamide by preparing THELES. Both APIs are sulfonylurea compounds used for the treatment of type 2 diabetes mellitus and have low solubility in water. To prepare the THELES, several coformers were tested, namely, tromethamine, L(+)-arginine, L-tryptophan, citric acid, malic acid, ascorbic acid, and p-aminobenzoic acid, in molar ratios of 1:1 and 1:2. To improve viscosity, water was added in different molar ratios to all systems. THELES were characterized by mid-infrared spectroscopy (MIR), and differential scanning calorimetry. Their viscosity, solubility, and permeability were also determined. Their stability at room temperature and 40 °C was accessed by MIR. Cytocompatibility was performed by metabolic activity and cell lysis evaluation, according to ISO10993-5:2009, and compared with the crystalline APIs. THELES with TRIS were successfully synthesized for both APIs. Results showed an increased solubility without a decrease in the permeability of the APIs in the THELES when compared with the pure APIs. The THELES were also considered stable for 8 weeks at ambient temperature. The cells studied showed that the THELES were not toxic for the cell lines used.
Highlights
IntroductionDeep Eutectic Systems (DES) are gaining widespread scientific and technological attention due to their advantages
Deep Eutectic Systems (DES) are defined as eutectic mixtures in which the depression of the melting point of the mixture is such that the mixture is liquid at room temperature [1,2].DESs are gaining widespread scientific and technological attention due to their advantages
This study showed that water has a role as an additional hydrogen bond donor (HBD) or hydrogen bond acceptor (HBA); they found out that the systems containing water had a lower depression of the melting point compared with the same system without water, suggesting that a controlled addition of water can be used to obtain deeper eutectics
Summary
DESs are gaining widespread scientific and technological attention due to their advantages. They are recognized as less volatile, thermally stable, biodegradable, less toxic, low in cost, and highly tunable due to the amount of different species that can constitute them [3,4,5]. The preparation of DESs is conducted according to Green. E.g., 100% atom economy, without the formation of by-products, and they can be considered green solvents and alternatives to organic solvents and ionic liquids [3,6]. DESs are normally comprised of a hydrogen bond acceptor (HBA) and a hydrogen bond donor (HBD). Strong noncovalent interactions between the HBA and Pharmaceuticals 2022, 15, 279.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.